QUIA PHARMA
0.004
SEK
-12.24 %
Less than 1K followers
QUIA
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
-12.24%
-28.48%
-49.6%
-70.92%
-79.64%
-91.67%
-99.93%
-100%
-100%
QUIA PHARMA operates in medical technology. The company has developed a technological platform that is used to develop existing pharmaceuticals. The technology is based on what is known as PEGylation, a technique that connects water-soluble polymers with the pharmaceuticals and is used to improve various characteristics in the biopharmaceuticals in regards to stability and resistance.
Read moreMarket cap
14.48M SEK
Turnover
27.48K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Financial calendar
26.6
2025
General meeting '25
28.8
2025
Interim report Q2'25
All
Press releases
ShowingAll content types
QuiaPEG has submitted a formal application to Nasdaq for the reverse acquisition of Rosemonkey Ltd.
QuiaPEG och Net Zero Infrastucture take next step to a formal license agreement
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools